N/A
Completed N=71
Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved Reliability
Laboring Women With Ultrasound and FSE Monitoring
Source: ClinicalTrials.gov NCT02024165 ↗
Enrolled (actual)
71
Serious AEs
0.0%
Results posted
May 2015
Primary outcomePrimary: Fetal Heart Rate Interpretability — 83.4; 62.4 percentage of time the signals are inter
Summary
The specific goal of the proposed research is to develop a reliable, non-invasive fetal and maternal heart rate and contraction monitor that is unaffected by obesity and requires less nursing intervention than the tocodynamometer and Doppler ultrasound.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Fetal Heart Rate Interpretability |
83.4; 62.4 | — |
Eligibility Criteria
Inclusion Criteria
- Parturients presenting to Labor & Delivery for labor at term (>36 weeks completed gestation)
- Single viable fetus in cephalic presentation
- With FSE or IUPC for obstetric indications
Exclusion Criteria
- Multi fetal gestation
- Contraindication to FSE or IUPC placement
- Insufficient abdominal space for all required sensors
Data sourced from ClinicalTrials.gov (NCT02024165). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.